A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
- PMID: 19607712
- PMCID: PMC2733898
- DOI: 10.1186/1471-2334-9-113
A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
Abstract
Background: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that they can use one or more specialized services during the study period. In 2004-2005, we conducted a national seroepidemiologic survey of DUs, based on a random sampling design using the Generalised Weight Share Method (GWSM) and on blood testing.
Methods: A cross-sectional multicenter survey was done among DUs having injected or snorted drugs at least once in their life. We conducted a two stage random survey of DUs selected to represent the diversity of drug use. The fact that DUs can use more than one structure during the study period has an impact on their inclusion probabilities. To calculate a correct sampling weight, we used the GWSM. A sociobehavioral questionnaire was administered by interviewers. Selected DUs were asked to self-collect a fingerprick blood sample on blotting paper.
Results: Of all DUs selected, 1462 (75%) accepted to participate. HCV seroprevalence was 59.8% [95% CI: 50.7-68.3]. Of DUs under 30 years, 28% were HCV seropositive. Of HCV-infected DUs, 27% were unaware of their status. In the month prior to interview, 13% of DUs shared a syringe, 38% other injection parapharnelia and 81% shared a crack pipe. In multivariate analysis, factors independently associated with HCV seropositivity were age over 30, HIV seropositivity, having ever injected drugs, opiate substitution treatment (OST), crack use, and precarious housing.
Conclusion: This is the first time that blood testing combined to GWSM is applied to a DUs population, which improve the estimate of HCV prevalence. HCV seroprevalence is high, indeed by the youngest DUs. And a large proportion of DUs are not aware of their status. Our multivariate analysis identifies risk factors such as crack consumption and unstable housing.
Figures


Similar articles
-
Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.Rev Epidemiol Sante Publique. 2016 Sep;64(4):301-12. doi: 10.1016/j.respe.2015.10.003. Epub 2016 Feb 19. Rev Epidemiol Sante Publique. 2016. PMID: 26904917
-
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.BMC Infect Dis. 2019 Dec 2;19(1):1022. doi: 10.1186/s12879-019-4655-2. BMC Infect Dis. 2019. PMID: 31791273 Free PMC article.
-
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).BMC Public Health. 2016 Sep 5;16(1):927. doi: 10.1186/s12889-016-3545-4. BMC Public Health. 2016. PMID: 27595567 Free PMC article.
-
Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.J Int AIDS Soc. 2015 May 22;18(1):19888. doi: 10.7448/IAS.18.1.19888. eCollection 2015. J Int AIDS Soc. 2015. PMID: 26004637 Free PMC article.
-
[HIV seroprevalence among drug users in Togo].Sante Publique. 2013 Jul-Aug;25(4):491-8. Sante Publique. 2013. PMID: 24404731 French.
Cited by
-
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.PLoS One. 2015 May 11;10(5):e0126920. doi: 10.1371/journal.pone.0126920. eCollection 2015. PLoS One. 2015. PMID: 25961575 Free PMC article.
-
Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants.AIDS Behav. 2024 Nov;28(11):3809-3818. doi: 10.1007/s10461-024-04453-5. Epub 2024 Aug 10. AIDS Behav. 2024. PMID: 39126558
-
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).Addiction. 2020 Mar;115(3):573-582. doi: 10.1111/add.14820. Epub 2019 Nov 20. Addiction. 2020. PMID: 31595554 Free PMC article.
-
Early cost-utility analysis of hepatitis C virus testing for emergency department attendees in France.PLOS Glob Public Health. 2023 Feb 23;3(2):e0001559. doi: 10.1371/journal.pgph.0001559. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36963042 Free PMC article.
-
A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France.Harm Reduct J. 2022 May 12;19(1):44. doi: 10.1186/s12954-022-00625-5. Harm Reduct J. 2022. PMID: 35550157 Free PMC article. No abstract available.
References
-
- Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47:1–39. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases